Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells

Nucleic Acids Res. 1990 Apr 25;18(8):2037-44. doi: 10.1093/nar/18.8.2037.

Abstract

A synthetic rev gene containing substitutions which introduced unique restriction sites but did not alter the deduced amino acid sequence was used as a vehicle to construct mutations in rev. Insertion or substitution mutations within a domain of Rev resulted in proteins able to inhibit the function of Rev protein in trans. Rev function was monitored in a cell line, HLfB, which contained a rev- mutant provirus. HLfB cells require the presence of rev for virus production, which was conveniently monitored by immunoblot detection of p24gag. Trans-dominant mutants were identified after expression in bacteria and delivery into HLfB cells by protoplast fusion. In addition, the trans-dominant phenotype was verified by expression of the mutant proteins in HLfB cells after cotransfection. These studies define a region between amino acid residues 81 and 88 of rev, in which different mutations result in proteins capable of inhibiting Rev function.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Cell Line
  • Cloning, Molecular
  • Escherichia coli / genetics
  • Gene Products, rev / biosynthesis
  • Gene Products, rev / genetics*
  • Genes, Synthetic
  • Genes, Viral*
  • Genes, rev*
  • HIV-1 / genetics*
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Phenotype
  • Trans-Activators / genetics*
  • Transfection*
  • rev Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, rev
  • Trans-Activators
  • rev Gene Products, Human Immunodeficiency Virus